MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

CI-1044

CAS No. : 197894-84-1

MCE 国际站：CI-1044

产品活性：CI-1044 是一种口服有效的 PDE4 抑制剂， 对 PDE4A5，PDE4B2，PDE4C2 和 PDE4D3 的 IC₅₀ 值分别为 0.29, 0.08, 0.56, 0.09 μM。

研究领域：Metabolic Enzyme/Protease

作用靶点：Phosphodiesterase (PDE)

In Vitro: CI-1044 is an orally active PDE4 inhibitor with IC₅₀s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5, PDE4B2, PDE4C2 and PDE4D3, respectively. CI-1044 selectively inhibits PDE4 crude extract from U937 cells with an IC₅₀ value of 0.27±0.02 μM being threefold more potent than rolipram (IC₅₀=0.91±0.14) and tenfold less potent than cilomilast (IC₅₀=0.026±0.007) in the same assay. In the presence of PDE4 inhibitors, the production of TNF-α is dose dependently decreased with mean IC₅₀ values from three separate experiments of 0.31±0.05, 0.26±0.05 and 0.11±0.01 μM, for CI-1044, cilomilast and rolipram, respectively.

In Vivo: TNF-α production is dose-dependently inhibited by CI-1044, rolipram and cilomilast with ID₅₀s of 0.4, 1.4 and 1.6 mg/kg respectively following single oral administration. Following repeated administration with CI-1044, the ID₅₀ value represents 0.5 mg/kg p.o.. CI-1044 plasma levels increase proportionally with doses ranging between 0.1 and 40 mg/kg p.o. (R2=0.878). CI-1044 dose dependently inhibits the accumulation of eosinophils in Bronchoalveolar lavages (BAL) fluids with an ID₅₀ value of 3.25 mg/kg. A single dose treatment with CI-1044 (10 mg/kg, p.o.) 24, 8, 3 or 1 h before the antigen challenge induces 6, 56, 48 and 79% inhibition in the number of eosinophils in BAL.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Orally Active Compound Library  |  Anti-Alzheimer's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Targeted Diversity Library  |  Anti-Colorectal Cancer Compound Library   |  Antidepressant Compound Library  |  Heterocyclic Compound Library  |  Cirsimarin  |  PDE11-IN-1  |  Enpp-1-IN-2  |  PAT-347  |  Vardenafil-d₅  |  Bay 60-7550  |  Deltarasin hydrochloride  |  HA155  |  Apremilast  |  Enpp-1-IN-6  |  Roflumilast  |  RS-25344 hydrochloride  |  PDE4-IN-6  |  Sp-cAMPS  |  ITI-214  |  Irsenontrine maleate  |  Lodenafil  |  Osoresnontrine  |  Deltasonamide 2  |  PF-07038124  |  Ziritaxestat  |  ATX inhibitor 22  |  Milrinone-d₃  |  Avanafil-¹³C,d₃  |  MT-3014  |  ATX inhibitor 19  |  Homo Sildenafil-d₅  |  Furamidine  |  PDE4-IN-12  |  Enpp-1-IN-8

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。